Our work suggests that the KCNQ channels in POMC neurons would be an alternative therapeutic target against obesity and type 2 diabetes as they are regulated by anorexigenic neurotransmitters and adipokines such as serotonin and apelin. Here, POMC is linked to obesity due to melanocortin 4 receptor deficiency.